Showing 211-220 of 1728 results for "".
Medical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.The Central Vein Sign
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-central-vein-sign/31627/Is 1.5 T MRI still relevant for diagnosis of multiple sclerosis?Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-what-do-animal-models-ofalzheimers-disease-tell-us/31560/Understanding pathologic mechanisms provides test beds for finding treatments.Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD
https://practicalneurology.com/programs/cme/safety-efficacy-and-black-box-warnings-challenges-associated-with-off-label-treatments-of-aad/27099/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Evaluating Heterogeneous Treatment Effects in Pursuit of Personalized Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/evaluating-heterogeneous-treatment-effects-in-pursuit-of-personalized-multiple-sclerosis-care/33141/Heterogeneous treatment effect methodologies can be used to enhance individualized care for people with multiple sclerosis.An Update on Nutraceuticals for Migraine Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-nutraceuticals-for-migraine-management/32132/Many people with migraine use integrative modalities, including nutraceutical supplements, along with mainstream medicine for disease control.Team Approach: Enhancing Collaboration in AAD Management
https://practicalneurology.com/programs/cme/team-approach-enhancing-collaboration-in-aad-management/27097/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Clinical Genetic Testing for Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-genetic-testing-for-alzheimer-disease-and-related-dementias/32139/Understanding the role of genetics in neurodegenerative dementia can help guide testing and improve clinical practice.Immune Checkpoint Inhibitor Neuromuscular Complications
https://practicalneurology.com/diseases-diagnoses/neuromuscular/immune-checkpoint-inhibitor-neuromuscular-complications/31922/Team-based approaches are needed to manage and better understand the adverse events of immune checkpoint inhibitors.Migraine During Pregnancy
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-during-pregnancy/31515/Developing plans for treatment during pregnancy before conception can relieve stress for both patient and provider.